NCT03423641View on ClinicalTrials.gov

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

CompletedOBSERVATIONAL
Enrollment

33,808

Participants

Timeline

Start Date

January 1, 2011

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Direct Acting Antivirals

The time period during which a patient is dispensed the medication and for up to 180 days after initiation of the medication.

Sponsors
All Listed Sponsors
collaborator

OneFlorida Clinical Research Consortium

OTHER

collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Kaiser Permanente

OTHER

NCT03423641 - An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C | Biotech Hunter | Biotech Hunter